journal article·2021-08Open access

Thiol-ene cross-linked alginate hydrogel encapsulation modulates the extracellular matrix of kidney organoids by reducing abnormal type 1a1 collagen deposition

Thomas Geuens, Floor A.A. Ruiter, Anika Schumacher, Francis L.C. Morgan, Timo Rademakers, Loes E. Wiersma, Cathelijne W. van den Berg, Ton J. Rabelink, Matthew B. Baker, Vanessa L.S. LaPointe

Biomaterials· Volume 275

Abstract

Differentiated kidney organoids from induced pluripotent stem cells hold promise as a treatment for patients with kidney diseases. Before these organoids can be translated to the clinic, shortcomings regarding their cellular and extracellular compositions, and their developmental plateau need to be overcome. We performed a proteomic analysis on kidney organoids cultured for a prolonged culture time and we found a specific change in the extracellular matrix composition with increased expression of types 1a1, 2 and 6a1 collagen. Such an excessive accumulation of specific collagen types is a hallmark of renal fibrosis that causes a life-threatening pathological condition by compromising key functions of the human kidney. Here we hypothesized the need for a three-dimensional environment to grow the kidney organoids, which could better mimic the in vivo surroundings of the developing kidney than standard culture on an air-liquid interface. Encapsulating organoids for four days in a soft, thiol-ene cross-linked alginate hydrogel resulted in decreased type 1a1 collagen expression. Furthermore, the encapsulation did not result in any changes of organoid structural morphology. Using a biomaterial to modulate collagen expression allows for a prolonged kidney organoid culture in vitro and a reduction of abnormal type 1a1 collagen expression bringing kidney organoids closer to clinical application.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Renal and related cancers · Tissue Engineering and Regenerative Medicine · Renal cell carcinoma treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Global prevalence of chronic kidney disease – a systematic review and meta-analysis10.1371/journal.pone.0158765 ↗
2. Chronic kidney disease10.1038/nrdp.2017.88 ↗
3. Living donor age and kidney allograft half-life: implications for living donor paired exchange programs10.2215/CJN.09990911 ↗
4. Regenerative medicine in kidney disease10.1016/j.kint.2016.03.030 ↗
5. Tubuloids derived from human adult kidney and urine for personalized disease modeling10.1038/s41587-019-0048-8 ↗
6. Organoids as an in vitro model of human development and disease10.1038/ncb3312 ↗
7. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells10.1016/j.stem.2013.11.010 ↗
8. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids10.1038/ncomms9715 ↗
9. Nephron organoids derived from human pluripotent stem cells model kidney development and injury10.1038/nbt.3392 ↗
10. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis10.1038/nature15695 ↗
11. Higher-order kidney organogenesis from pluripotent stem cells10.1016/j.stem.2017.10.011 ↗
12. Overcoming kidney organoid challenges for regenerative medicine10.1038/s41536-020-0093-4 ↗
13. Comparative analysis and refinement of human PSC-derived kidney organoid differentiation with single-cell transcriptomics10.1016/j.stem.2018.10.010 ↗
14. Generation of kidney organoids from human pluripotent stem cells10.1038/nprot.2016.098 ↗
15. Fibroblasts and myofibroblasts in renal fibrosis10.1111/j.1365-2613.2011.00764.x ↗
16. Extracellular matrix in kidney fibrosis: more than just a scaffold10.1369/0022155419849388 ↗
17. Fibrosis in tissue engineering and regenerative medicine: treat or trigger?10.1016/j.addr.2019.07.007 ↗
18. The Perseus computational platform for comprehensive analysis of (prote)omics data10.1038/nmeth.3901 ↗
19. Renal subcapsular transplantation of PSC-derived kidney organoids induces neo-vasculogenesis and significant glomerular and tubular maturation in vivo10.1016/j.stemcr.2018.01.041 ↗
20. What is the best way to measure renal fibrosis?: a pathologist's perspective10.1038/kisup.2014.3 ↗
21. Thiol–ene alginate hydrogels as versatile bioinks for bioprinting10.1021/acs.biomac.8b00696 ↗
22. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures10.1126/science.1131000 ↗
23. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?10.1186/1755-1536-7-4 ↗
24. Renal interstitial fibrosis: an imperfect predictor of kidney disease progression in some patient cohorts10.1159/000449511 ↗
25. Chapter 9 alginates as biomaterials in tissue engineering, carbohydrate chemistry
26. Alginate-based biomaterials for regenerative medicine applications10.3390/ma6041285 ↗
27. Protein release from alginate matrices10.1016/j.addr.2012.09.007 ↗
28. Composite alginate gels for tunable cellular microenvironment mechanics10.1038/srep30854 ↗
29. Tunable injectable alginate-based hydrogel for cell therapy in type 1 diabetes mellitus10.1016/j.ijbiomac.2017.09.103 ↗
30. A rapid method for determining protein diffusion through hydrogels for regenerative medicine applications10.1063/1.4999925 ↗
31. Overview of the cellular and molecular basis of kidney fibrosis10.1038/kisup.2014.2 ↗
32. Cellular origin and functional relevance of collagen I production in the kidney10.1681/ASN.2018020138 ↗
33. Engineered materials for organoid systems10.1038/s41578-019-0129-9 ↗
34. Protein-engineered scaffolds for in vitro 3D culture of primary adult intestinal organoids10.1039/C5BM00108K ↗
35. Synthesis and characterization of well-defined hydrogel matrices and their application to intestinal stem cell and organoid culture10.1038/nprot.2017.095 ↗
36. Synthetic hydrogels for human intestinal organoid generation and colonic wound repair10.1038/ncb3632 ↗
37. Nonadhesive alginate hydrogels support growth of pluripotent stem cell-derived intestinal organoids10.1016/j.stemcr.2018.12.001 ↗
38. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation10.1038/nprot.2016.097 ↗
39. 3D heterogeneous islet organoid generation from human embryonic stem cells using a novel engineered hydrogel platform10.1016/j.biomaterials.2018.05.031 ↗
40. Neural tube morphogenesis in synthetic 3D microenvironments10.1073/pnas.1603529113 ↗
41. Growth of epithelial organoids in a defined hydrogel10.1002/adma.201801621 ↗
42. Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells10.1038/s41563-019-0287-6 ↗
43. Collagen organization deposited by fibroblasts encapsulated in pH responsive methacrylated alginate hydrogels10.1002/jbm.a.36482 ↗
44. Kidney decellularized extracellular matrix hydrogels: rheological characterization and human glomerular endothelial cell response to encapsulation10.1002/jbm.a.36439 ↗
45. Decellularized human kidney cortex hydrogels enhance kidney microvascular endothelial cell maturation and quiescence10.1089/ten.tea.2016.0213 ↗
46. Hydrazone covalent adaptable networks modulate extracellular matrix deposition for cartilage tissue engineering10.1016/j.actbio.2018.11.014 ↗
47. An enzyme-sensitive PEG hydrogel based on aggrecan catabolism for cartilage tissue engineering10.1002/adhm.201400277 ↗
48. Tissue stiffness dictates development, homeostasis, and disease progression10.1080/15476278.2015.1019687 ↗
49. Linear viscoelastic behavior of subcutaneous adipose tissue
50. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer10.1242/dmm.004077 ↗
51. Anatomical locations of human brown adipose tissue: functional relevance and implications in obesity and type 2 diabetes10.2337/db12-1430 ↗